Antipsychotic prescribing patterns by dermatologists in the Medicare population

Antipsychotic prescribing patterns by dermatologists in the Medicare population

Saved in:

Bibliographic Details
Main Authors:	Areebah S. Ahmad, BA, Daphne Thampy, MPH, Marina Kristy Ibraheim, MD, Christina Kraus, MD, Harry Dao, Jr., MD, Ashley Elsensohn, MPH, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-08-01
Series:	JAAD International
Subjects:	antipsychotics dermatology epidemiology Medicare prescription claims psychiatry
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666328725000458
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Geographic and socioeconomic disparities contribute to variation in opioid prescription patterns in the Medicare Part D population: A cross-sectional study
by: Lauren N. McGrath, BA, et al.
Published: (2025-08-01)

Spillover Effects of Medicare Advantage on Traditional Medicare Beneficiaries With Prostate Cancer
by: Arnav Srivastava, et al.
Published: (2025-03-01)

Knowledge and awareness in psychodermatology: Findings from a survey among Ibero-Latin American dermatologists
by: Julio Torales, et al.
Published: (2025-01-01)

U.S. adults with diagnosed diabetes enrolled in Medicare by age and insurance type
by: Barbara H. Bardenheier, et al.
Published: (2025-08-01)

Follow-Up of Delirium Patients: Antipsychotic Use Can Be Another Confounding Factor for Prognosis
by: Arda Bağcaz
Published: (2025-01-01)

Antipsychotics use in the community of Thessaloniki, Greece
by: Papaioannidou Paraskevi, et al.
Published: (2018-01-01)

Declining Service Labor Rates for Total Hip and Total Knee Arthroplasty in Medicare Patients
by: John M. Dundon, MD, FAAOS, et al.
Published: (2025-06-01)

Virtual nurse support to enhance antipsychotic adherence in schizophrenia: A South African perspective
by: Yasmeen Thandar, et al.
Published: (2025-05-01)

Intercostal Nerve Cryoablation During Lobectomy for Postsurgical Pain: A Safe and Cost-Effective Intervention
by: Daniel L. Miller, et al.
Published: (2024-12-01)

Clinical prescription of lithium, anticonvulsants antipsychotics, and antidepressants for major mood disorders
by: Carolina Hernandorena, et al.
Published: (2025-07-01)

Trends in Medicare Utilization and Reimbursement for Traumatic Brain Injury: 2003–2021
by: Sean Inzerillo, et al.
Published: (2024-10-01)

P2Y12 Inhibitors Refill Gap Predicts Death in Medicare Beneficiaries on Chronic Dialysis
by: Rafia S. Rasu, et al.
Published: (2024-07-01)

Health care utilization among Medicare beneficiaries with newly diagnosed back pain
by: Maria Isabel Barros Guinle, BA, et al.
Published: (2024-12-01)

Incidence and Prevalence of Alzheimer’s Disease in Medicare Beneficiaries
by: Haixin Zhang, et al.
Published: (2024-12-01)

Antipsychotics and rashes
by: Jessica Lin
Published: (2018-11-01)

Twenty-five year trend in antipsychotic medication prescribing in England: challenges and opportunities
by: Hannah Newman, et al.
Published: (2025-07-01)

Trends and Factors Associated With Peripheral Vascular Interventions for the Treatment of Claudication From 2011 to 2022: A National Medicare Cohort Study
by: Chen Dun, et al.
Published: (2024-07-01)

Understanding Medicare-related decision-making by older adults: Role of technology support
by: Hye Soo Lee, et al.
Published: (2025-06-01)

INVESTIGATING THE USE OF TRADITIONAL MEDICARE APPLICATION IN THREE SELECTED CHURCHES IN LAGOS, NIGERIA
by: ABILAWON OLUWASEUN FUNMI
Published: (2025-07-01)

Knowledge is Power: An Analysis of Counseling Professionals’ Medicare Policy Proficiency
by: Matthew C. Fullen, et al.
Published: (2020-08-01)

Comparative Analysis of Time to All-cause Treatment Discontinuation and Rehospitalization among Early-phase Schizophrenia Patients Discharged on Long-acting Injectable Antipsychotics versus Oral Antipsychotics
by: Ta-Chun Lin, et al.
Published: (2025-01-01)

FR - Actualización en el tratamiento de los principales trastornos psicodermatológicos
by: O. Alwattar-Ceballos, et al.
Published: (2024-11-01)

Medicare Advantage penetration and the financial distress of rural hospitals
by: Guido Cataife, et al.
Published: (2025-02-01)

Clinical Efficacy of Telemedicine for Musculoskeletal Conditions in a Medicare Advantage Population
by: Mary I. O’Connor, et al.
Published: (2025-01-01)

Pharmacotherapy of Psychotic Disorders in Türkiye: Insights From a National Prescription Database
by: Sena Türkeş, et al.
Published: (2025-07-01)

Comparative analysis of antipsychotic drug consumption for inpatient schizophrenia treatment: a retrospective study with 5-year follow-up
by: L. B. Vaskova, et al.
Published: (2020-11-01)

Evolution of Healthcare Economics: Blockchain Integration Amidst Medicare Reform
by: Ryan Wright
Published: (2025-04-01)

Cost Consciousness Among Dermatologists
by: AlFada MA
Published: (2025-01-01)

Differential Trends in Health Care Utilization and Spending Among Asian American and Pacific Islander Medicare Beneficiaries before and During the COVID-19 Pandemic
by: Taylor Melanson, et al.
Published: (2024-12-01)

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-08-01)

Mutism and rigidity due to antipsychotic‐induced catatonia improved by hemodialysis: A case report
by: Rintaro Fujii, et al.
Published: (2025-03-01)

Development of the Health Disparities Prevention Quality Index for Medicare Accountable Care Organizations
by: Andrew Anderson, et al.
Published: (2025-02-01)

Impact of insurance payer type (medicare vs. private) on the patient reported outcomes after shoulder arthroplasty
by: Paul V. Romeo, MD, et al.
Published: (2025-01-01)

Control, access and professionalism: a qualitative evaluation of Australian dental practitioners attitudes to expanding medicare to include more dental services
by: Alexander C. L. Holden, et al.
Published: (2025-07-01)

Teledermatology: Canadian dermatologists’ practice patterns, perceived challenges and future recommendations
by: Sidra Sarfaraz, et al.
Published: (2025-02-01)

Study of factors associated with obesity in patients using antipsychotics in schizophrenia
by: Vishalakshi Patnam, et al.
Published: (2024-12-01)

Evolution of Drug Supply for Psoriasis from 2010 to 2022 &ndash; Real-World Claims Data Analysis in Germany
by: Hagenström K, et al.
Published: (2025-06-01)

Differences in the relationship between medication adherence and payer medical costs across three quality measures: results of a cohort study among medicare advantage beneficiaries
by: Sujith Ramachandran, et al.
Published: (2025-08-01)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-05-01)

Economic outcomes of diabetes self-management education among older Medicare beneficiaries with diabetes
by: Gang Lv, et al.
Published: (2025-05-01)